Literature DB >> 17633022

Molecular basis for the unique specificity of TRAF6.

Jee Y Chung1, Miao Lu, Qian Yin, Su-Chang Lin, Hao Wu.   

Abstract

Tumor necrosis factor (TNF) receptor (TNFR) associated factor 6 (TRAF6) is a unique member of the TRAF family of adaptor proteins that is involved in both the TNF receptor superfamily and the interleukin-1 receptor (IL-1R)/Toll-like receptor (TLR) superfamily signal transduction pathways. The ability to mediate signals from both families of receptors implicates TRAF6 as an important regulator of a diverse range of physiological processes such as innate and adaptive immunity, bone metabolism, and the development of lymph nodes, mammary glands, skin, and the central nervous system. This chapter will highlight the structural and biochemical studies of TRAF6 in receptor interactions and discuss the potential for peptidomimetic drug application based on TRAF6 receptor binding motif.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17633022     DOI: 10.1007/978-0-387-70630-6_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  29 in total

1.  A novel motif in the Crohn's disease susceptibility protein, NOD2, allows TRAF4 to down-regulate innate immune responses.

Authors:  Jill M Marinis; Craig R Homer; Christine McDonald; Derek W Abbott
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

2.  Mutational analysis of TRAF6 reveals a conserved functional role of the RING dimerization interface and a potentially necessary but insufficient role of RING-dependent TRAF6 polyubiquitination towards NF-κB activation.

Authors:  Charilaos Megas; Eudoxia G Hatzivassiliou; Qian Yin; Elli Marinopoulou; Paul Hadweh; Dario A A Vignali; George Mosialos
Journal:  Cell Signal       Date:  2010-12-23       Impact factor: 4.315

3.  Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF).

Authors:  Dongxu Sun; Michael Novotny; Katarzyna Bulek; Caini Liu; Xiaoxia Li; Thomas Hamilton
Journal:  Nat Immunol       Date:  2011-08-07       Impact factor: 25.606

Review 4.  TRAF6 activation in multiple myeloma: a potential therapeutic target.

Authors:  Hong Liu; Samantha Tamashiro; Stavroula Baritaki; Manuel Penichet; Youhua Yu; Haiming Chen; James Berenson; Benjamin Bonavida
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-03-21

Review 5.  TWEAK and TRAF6 regulate skeletal muscle atrophy.

Authors:  Ashok Kumar; Shephali Bhatnagar; Pradyut K Paul
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-05       Impact factor: 4.294

6.  The Ran-binding protein RanBPM can depress the NF-κB pathway by interacting with TRAF6.

Authors:  Lan Wang; Chengbo Fu; Yingbin Cui; Yunfei Xie; Yuhe Yuan; Xin Wang; Hong Chen; Bing-Ren Huang
Journal:  Mol Cell Biochem       Date:  2011-07-30       Impact factor: 3.396

Review 7.  Toll-Like Receptor Pathways in Autoimmune Diseases.

Authors:  Ji-Qing Chen; Peter Szodoray; Margit Zeher
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

8.  Reciprocal interaction between TRAF6 and notch signaling regulates adult myofiber regeneration upon injury.

Authors:  Sajedah M Hindi; Pradyut K Paul; Saurabh Dahiya; Vivek Mishra; Shephali Bhatnagar; Shihuan Kuang; Yongwon Choi; Ashok Kumar
Journal:  Mol Cell Biol       Date:  2012-10-01       Impact factor: 4.272

9.  A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients.

Authors:  Marco Agostini; Andrea Zangrando; Chiara Pastrello; Edoardo D'Angelo; Gabriele Romano; Roberto Giovannoni; Marco Giordan; Isacco Maretto; Chiara Bedin; Carlo Zanon; Maura Digito; Giovanni Esposito; Claudia Mescoli; Marialuisa Lavitrano; Flavio Rizzolio; Igor Jurisica; Antonio Giordano; Salvatore Pucciarelli; Donato Nitti
Journal:  Cancer Biol Ther       Date:  2015-05-29       Impact factor: 4.742

10.  TRAF6 regulates satellite stem cell self-renewal and function during regenerative myogenesis.

Authors:  Sajedah M Hindi; Ashok Kumar
Journal:  J Clin Invest       Date:  2015-11-30       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.